rBTI induces apoptosis in human solid tumor cell lines by loss in mitochondrial transmembrane potential and caspase

Yu-Ying Li1, Zheng Zhang, Zhuan-Hua Wang

  • 1Key Laboratory for Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Biotechnology, Shanxi University, 36 Wucheng Road, Taiyuan, 030006, China.

Toxicology Letters
|June 2, 2009
PubMed

Insights

Recombinant buckwheat trypsin inhibitor (rBTI) effectively inhibits solid tumor cell growth and induces apoptosis. This occurs via the mitochondrial pathway, involving key proteins and caspase activation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Solid tumors represent a significant global health challenge.
  • Targeted therapies inducing apoptosis are crucial for cancer treatment.
  • Understanding novel apoptosis inducers like recombinant buckwheat trypsin inhibitor (rBTI) is essential.

Purpose of the Study:

  • To investigate the molecular mechanisms and effects of rBTI on human solid tumor cell apoptosis.
  • To determine if rBTI can induce programmed cell death in cancer cells.
  • To elucidate the specific apoptotic pathway activated by rBTI.

Main Methods:

  • MTT assay for cell growth inhibition.
  • Flow cytometry for apoptosis analysis.
  • DNA electrophoresis for apoptosis detection.
  • Mitochondrial pathway analysis (Bax, Bak, Bcl-2, Bcl-xl, cytochrome c, caspase-3, -9, Deltapsi(m)).

Main Results:

  • rBTI specifically inhibited solid tumor cell growth dose- and time-dependently.
  • rBTI treatment increased apoptosis in tumor cells (EC9706, HepG2, HeLa).
  • Apoptosis involved mitochondrial pathway activation: Bax/Bak up-regulation, Bcl-2/Bcl-xl down-regulation, cytochrome c release, caspase-3/-9 activation, and mitochondrial potential disruption.
  • Caspase-3 inhibition partially blocked rBTI-induced apoptosis.

Conclusions:

  • rBTI induces apoptosis in human solid tumor cells.
  • The mechanism involves the mitochondrial apoptotic pathway.
  • rBTI shows potential as a therapeutic agent for solid tumors.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.